Valinor Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VALINOR, and what generic alternatives to VALINOR drugs are available?
VALINOR has one approved drug.
There are four US patents protecting VALINOR drugs.
There are one hundred and one patent family members on VALINOR drugs in forty-four countries and eighteen supplementary protection certificates in fifteen countries.
Drugs and US Patents for Valinor
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | 8,067,431 | ⤷ Sign Up | ⤷ Sign Up | ||||
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-001 | Sep 16, 2014 | RX | Yes | No | 7,056,500 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | 7,786,133 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | 7,056,500 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-001 | Sep 16, 2014 | RX | Yes | No | 7,786,133 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-001 | Sep 16, 2014 | RX | Yes | No | 8,067,431 | ⤷ Sign Up | ⤷ Sign Up | ||||
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | RX | Yes | Yes | 9,012,469 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Valinor
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-001 | Sep 16, 2014 | 7,056,500 | ⤷ Sign Up |
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | 7,056,500 | ⤷ Sign Up |
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | 8,617,530 | ⤷ Sign Up |
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-002 | Sep 16, 2014 | 7,662,365 | ⤷ Sign Up |
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-001 | Sep 16, 2014 | 8,617,530 | ⤷ Sign Up |
Valinor | MOVANTIK | naloxegol oxalate | TABLET;ORAL | 204760-001 | Sep 16, 2014 | 7,662,365 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALINOR drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 12.5 mg and 25 mg | ➤ Subscribe | 2018-09-17 |
International Patents for Valinor Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Slovenia | 1436012 | ⤷ Sign Up |
Croatia | P20151420 | ⤷ Sign Up |
Ecuador | SP13012531 | ⤷ Sign Up |
Ukraine | 112847 | ⤷ Sign Up |
European Patent Office | 2236161 | ⤷ Sign Up |
China | 1925875 | ⤷ Sign Up |
Netherlands | 300737 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Valinor Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1694363 | 234 5008-2015 | Slovakia | ⤷ Sign Up | PRODUCT NAME: OXALAT NALOXEGOLU; REGISTRATION NO/DATE: EU/1/14/962 20141210 |
1694363 | 1590027-7 | Sweden | ⤷ Sign Up | PRODUCT NAME: NALOXEGOL; REG. NO/DATE: EU/1/14/962 20141210 |
1694363 | 15C0037 | France | ⤷ Sign Up | PRODUCT NAME: NALOXEGOL OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES,EN PARTICULIER L'OXALATE DE NALOXEGOL; REGISTRATION NO/DATE: EU/1/14/962 20141210 |
1694363 | C300737 | Netherlands | ⤷ Sign Up | PRODUCT NAME: NALOXEGOL ALSMEDE DOOR HET BASISOCTROOI; REGISTRATION NO/DATE: EU/1/14/962 20141208 |
1694363 | 300737 | Netherlands | ⤷ Sign Up | PRODUCT NAME: NALOXEGOL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER NALOGEXOLOXALAAT; REGISTRATION NO/DATE: EU/1/14/962 20141210 |
1694363 | 27/2015 | Austria | ⤷ Sign Up | PRODUCT NAME: NALOXEGOL, GEGEBENENFALLS IN FORM EINES THERAPEUTISCH VERTRAEGLICHEN SALZES, INSBESONDERE ALS OXALAT; REGISTRATION NO/DATE: EU/1/14/962 20141208 |
1694363 | C01694363/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: NALOXEGOLUM; REGISTRATION NO/DATE: SWISSMEDIC 65205 08.07.2015 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.